Jade Biosciences annual operating expenses
2020
2021
2022
2023
2024
2025
Jade Biosciences Operating Expenses Growth & History (JBIO)
Jade Biosciences's operating expenses was $113.5M for fiscal 2025.
View full Jade Biosciences company overviewJade Biosciences annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $113.5M | $38.9M | +52.21% |
| 2024 | 2024-12-31 | $74.6M | −$6.8M | −8.37% |
| 2023 | 2023-12-31 | $81.4M | $28.2M | +52.92% |
| 2022 | 2022-12-31 | $53.2M | $30.2M | +131.24% |
| 2021 | 2021-12-31 | $23.0M | $14.1M | +158.99% |
| 2020 | 2020-12-31 | $8.9M | — | — |
Jade Biosciences quarterly operating expenses
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $58.9M | $31.1M | +112.10% |
| Q1 2026 | 2026-03-31 | $43.4M | $20.1M | +85.79% |
| Q4 2025 | 2025-12-31 | $35.0M | $26.1M | +295.33% |
| Q3 2025 | 2025-09-30 | $27.4M | $12.4M | +83.10% |
| Q2 2025 | 2025-06-30 | $27.8M | $1.6M | +6.16% |
| Q1 2025 | 2025-03-31 | $23.4M | −$1.2M | −5.01% |
| Q4 2024 | 2024-12-31 | $8.8M | −$13.2M | −59.90% |
| Q3 2024 | 2024-09-30 | $15.0M | −$6.4M | −29.97% |
| Q2 2024 | 2024-06-30 | $26.2M | $5.8M | +28.66% |
| Q1 2024 | 2024-03-31 | $24.6M | $7.0M | +39.57% |
| Q4 2023 | 2023-12-31 | $22.1M | $6.2M | +39.21% |
| Q3 2023 | 2023-09-30 | $21.4M | $7.2M | +50.99% |
| Q2 2023 | 2023-06-30 | $20.3M | $8.1M | +66.48% |
| Q1 2023 | 2023-03-31 | $17.6M | $6.6M | +60.08% |
| Q4 2022 | 2022-12-31 | $15.9M | $7.6M | +91.72% |
| Q3 2022 | 2022-09-30 | $14.2M | $8.0M | +128.26% |
| Q2 2022 | 2022-06-30 | $12.2M | $6.4M | +111.55% |
| Q1 2022 | 2022-03-31 | $11.0M | $8.2M | +296.37% |
| Q4 2021 | 2021-12-31 | $8.3M | — | — |
| Q3 2021 | 2021-09-30 | $6.2M | $4.0M | +176.42% |
| Q2 2021 | 2021-06-30 | $5.8M | $4.1M | +255.32% |
| Q1 2021 | 2021-03-31 | $2.8M | — | — |
| Q3 2020 | 2020-09-30 | $2.2M | — | — |
| Q2 2020 | 2020-06-30 | $1.6M | — | — |
Jade Biosciences operating expenses trends
Over the last five fiscal years, Jade Biosciences's operating expenses increased from $8.9M to $113.5M, a change of $104.7M. The latest reported quarter, Q2 2026, shows $58.9M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Jade Biosciences source filings ↗